Dataset Information

Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia.

ABSTRACT:

Introduction

Measurement of physical activity (PA) using commercial activity trackers such as Fitbit devices has become increasingly popular, also for people with haemophilia (PWH). The accuracy of the Fitbit model Charge 3 has not yet been examined.

Aims

To compare the Fitbit Charge 3 against the research-grade accelerometer ActiGraph GT3X-BT in measuring average daily steps and minutes spent in different PA intensities.

Methods

Twenty-four young PWH wore a wrist-worn Fitbit Charge 3 and hip-worn ActiGraph GT3X-BT simultaneously for seven consecutive days in free-living conditions. Correlation of and differences between the devices for daily averages of PA parameters were assessed using Pearson's correlation coefficient and paired t-test, respectively. Agreement between devices was assessed using Bland-Altman plots.

Results

Twenty participants (mean age 21.8) were included in the analyses. We found moderate to high correlations between Fitbit and ActiGraph measured daily averages for all PA variables, but statistically significant differences between devices for all variables except daily minutes of moderate PA. Fitbit overestimated average daily steps, minutes of light, vigorous and moderate-to-vigorous PA. Bland-Altman plots showed a measurement bias between devices for all parameters with increasing overestimation by the Fitbit for higher volumes of PA.

Conclusion

The Fitbit Charge 3 overestimated steps and minutes of light, moderate and moderate-to-vigorous PA as compared to the ActiGraph GT3X-BT, and this bias increased with PA volume. The Fitbit should therefore be used with caution in research, and we advise users of the device to be cognizant of this overestimation.

SUBMITTER: Matlary RED

PROVIDER: S-EPMC9796296 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia.

Matlary Ruth Elise D RED Holme Pål André PA Glosli Heidi H Rueegg Corina Silvia CS Grydeland May M

Haemophilia : the official journal of the World Federation of Hemophilia 20220713 6

<h4>Introduction</h4>Measurement of physical activity (PA) using commercial activity trackers such as Fitbit devices has become increasingly popular, also for people with haemophilia (PWH). The accuracy of the Fitbit model Charge 3 has not yet been examined.<h4>Aims</h4>To compare the Fitbit Charge 3 against the research-grade accelerometer ActiGraph GT3X-BT in measuring average daily steps and minutes spent in different PA intensities.<h4>Methods</h4>Twenty-four young PWH wore a wrist-worn Fitb ...[more]

PMID: 35830613

Similar Datasets

Project description:Objectives: Our count-scaled algorithm automatically scores sleep across 24 hours to process sleep timing, quantity, and quality. The aim of this study was to validate the algorithm against overnight PSG in children to determine the best site placement for sleep. Methods: 28 children (5-8 years) with no history of sleep disturbance wore two types of accelerometers (ActiGraph GT3X+ and Actical) at two sites (left hip, non-dominant wrist) for 24-h. Data were processed using the count-scaled algorithm. PSG data were collected using an in-home Type 2 device. PSG-actigraphy epoch sensitivity (sleep agreement) and specificity (wake agreement) were determined and sleep outcomes compared for timing (onset and offset), quantity [sleep period time (SPT) and total sleep time (TST)], and quality metrics [sleep efficiency and waking after sleep onset (WASO)]. Results: Overall, sensitivities were high (89.1% to 99.5%) and specificities low (21.1% to 45.7%). Sleep offset was accurately measured by actigraphy, regardless of brand or placement site. By contrast, sleep onset agreed with PSG using hip-positioned but not wrist-positioned devices (difference ActiGraph : PSG 21 min, P < .001; Actical : PSG 14 min, P < .001). The ActiGraph at the wrist accurately detected WASO and sleep efficiency, but under (-34 min, P < .001) and overestimated (5.8%, P < .001) these at the hip. The Actical under- and over-estimated these variables respectively at both sites. Results for TST varied ranging from significant differences to PSG of -26 to 21 min (ActiGraph wrist and hip respectively) and 9 min (ns) to 59 min for Actical (wrist and hip respectively). Conclusion: Overall the count-scaled algorithm produced high sensitivity at the expense of low specificity in comparison with PSG. A best site placement for estimates of all sleep variables could not be determined, but overall the results suggested ActiGraph GT3X+ at the hip may be superior for sleep timing and quantity metrics, whereas the wrist may be superior for sleep quality metrics. Both devices placed at the hip performed well for sleep timing but not for sleep quality. Differences are likely linked to freedom of movement of the wrist vs the trunk (hip) during overnight sleep.

Project description:BackgroundPhysical activity (PA) is reduced in persons with multiple sclerosis (MS), though it is known to aid in symptom and fatigue management. Methods for measuring PA are diverse and the impact of this heterogeneity on study outcomes is unclear. We aimed to clarify this impact by comparing common methods for deriving PA metrics in MS populations.MethodsFirst, a rapid review of existing literature identified methods for calculating PA in studies which used the Actigraph GT3X in populations with MS. We then compared methods in a prospective study on 42 persons with MS [EDSS 4.5 (3.5-6)] during a voluntary course of inpatient neurorehabilitation. Mixed-effects linear regression identified methodological factors which influenced PA measurements. Non-parametric hypothesis tests, correlations, and agreement statistics assessed overall and pairwise differences between methods.ResultsIn the rapid review, searches identified 421 unique records. Sixty-nine records representing 51 eligible studies exhibited substantial heterogeneity in methodology and reporting practices. In a subsequent comparative study, multiple methods for deriving six PA metrics (step count, activity counts, total time in PA, sedentary time, time in light PA, time in moderate to vigorous PA), were identified and directly compared. All metrics were sensitive to methodological factors such as the selected preprocessing filter, data source (vertical vs. vector magnitude counts), and cutpoint. Additionally, sedentary time was sensitive to wear time definitions. Pairwise correlation and agreement between methods varied from weak (minimum correlation: 0.15, minimum agreement: 0.03) to perfect (maximum correlation: 1.00, maximum agreement: 1.00). Methodological factors biased both point estimates of PA and correlations between PA and clinical assessments.ConclusionsMethodological heterogeneity of existing literature is high, and this heterogeneity may confound studies which use the Actigraph GT3X. Step counts were highly sensitive to the filter used to process raw accelerometer data. Sedentary time was particularly sensitive to methodology, and we recommend using total time in PA instead. Several, though not all, methods for deriving light PA and moderate to vigorous PA yielded nearly identical results. PA metrics based on vertical axis counts tended to outperform those based on vector magnitude counts. Additional research is needed to establish the relative validity of existing methods.

Dataset Information

Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia.

Introduction

Aims

Methods

Results

Conclusion

Publications

Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets